← Back to Screener
Nautilus Biotechnolgy, Inc. Common Stock (NAUT)
Price$2.39
Momentum ScoreB
Favorite Metrics
Price vs S&P 500 (26W)-1.70%
Price vs S&P 500 (4W)-10.81%
VGM Score71.13
Market Capitalization$303.72M
All Metrics
Book Value / Share (Quarterly)$1.14
P/TBV (Annual)1.19x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.40
Price vs S&P 500 (YTD)14.41%
EPS (TTM)$-0.45
10-Day Avg Trading Volume0.44M
EPS Excl Extra (TTM)$-0.45
EPS (Annual)$-0.47
ROI (Annual)-37.59%
Cash / Share (Quarterly)$0.75
ROA (Last FY)-30.87%
EBITD / Share (TTM)$-0.50
ROE (5Y Avg)-25.55%
Cash Flow / Share (Annual)$-0.41
P/B Ratio2.10x
P/B Ratio (Quarterly)3.40x
Net Income / Employee (Annual)$-464,600
ROA (TTM)-29.16%
EPS Incl Extra (Annual)$-0.47
Current Ratio (Annual)13.33x
Quick Ratio (Quarterly)11.49x
3-Month Avg Trading Volume0.33M
52-Week Price Return222.10%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$2.22
52-Week High$4.31
EPS Excl Extra (Annual)$-0.47
CapEx CAGR (5Y)6.78%
26-Week Price Return6.22%
Quick Ratio (Annual)13.00x
13-Week Price Return-2.05%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)11.85x
Enterprise Value$289.09M
Book Value / Share Growth (5Y)14.37%
Revenue / Employee (Annual)$0
Cash / Share (Annual)$0.82
3-Month Return Std Dev95.55%
Net Income / Employee (TTM)$-449,500
ROE (Last FY)-37.59%
EPS Basic Excl Extra (Annual)$-0.47
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-0.45
ROI (TTM)-35.04%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$2.52
Price vs S&P 500 (52W)197.74%
Year-to-Date Return22.56%
5-Day Price Return-13.72%
EPS Normalized (Annual)$-0.47
ROA (5Y Avg)-22.01%
Month-to-Date Return-12.77%
Cash Flow / Share (TTM)$-0.47
EBITD / Share (Annual)$-0.52
ROI (5Y Avg)-25.55%
EPS Basic Excl Extra (TTM)$-0.45
P/TBV (Quarterly)1.35x
P/B Ratio (Annual)1.57x
Book Value / Share (Annual)$1.24
Price vs S&P 500 (13W)-10.30%
Beta0.79x
Revenue / Share (TTM)$0.00
ROE (TTM)-35.04%
52-Week Low$0.62
mGradeB
vgmGradeB
Show chart for
Earnings Surprise History
Q1 26-0.12est. -0.15
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
4.25
4.25
4.25
4.25
Industry Peers — Lab Analytical Instruments(24)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
NAUTNautilus Biotechnolgy, Inc. Common Stock | — | — | B | $2.39 |
| AAgilent Technologies Inc. | C | C | B | $135.44 |
| WATWaters Corp | D | C | C | $365.36 |
| ILMNIllumina Inc | D | D | B | $162.32 |
| MTDMettler-Toledo International | D | C | C | $1154.33 |
| RVTYRevvity, Inc. | C | D | C | $98.37 |
| BRKRBruker Corporation | D | D | B | $56.39 |
| BIOBio-Rad Laboratories, Inc.Class A | C | F | B | $294.32 |
| BIO.BBio-Rad Laboratories, Inc. Class B | C | F | B | $304.15 |
| AVTRAvantor, Inc. | B | D | C | $9.16 |
| TXG10x Genomics, Inc. Class A Common Stock | D | C | A | $31.04 |
About
Nautilus Biotechnology develops a platform technology for high-throughput proteomics analysis, providing researchers with integrated tools to study the human proteome at scale. The company's offerings include proprietary mass spectrometry systems, reagent kits, and analysis software designed for research, diagnostics, and drug development. As a development-stage company, Nautilus aims to expand access to comprehensive protein analysis and accelerate advances in human health and medicine.